Soy Isoflavone Supplementation Not Effective In Breast Cancer Protection
Editor's ChoiceAcademic Journal
Main Category: Breast Cancer
Also Included In: Complementary Medicine / Alternative Medicine
Article Date: 08 Feb 2012 - 10:00 PST
'Soy Isoflavone Supplementation Not Effective In Breast Cancer Protection'
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
A study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, reveals that breast cancer cell proliferation was not lowered with soy isoflavone supplements in a randomized human trial. Isoflavone are components of soy foods believed to have anti-estrogen activity.
Results of the study are consistent with findings from earlier investigations that were designed to examine cancer prevention benefits of dietary supplements, according to lead researcher Seema A. Khan, M.D., professor of surgery at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Khan explains:
"Simply put, supplements are not food. Although soy-based foods appear to have a protective effect, we are not seeing the same effect with supplementation using isolated components of soy, so the continued testing of soy supplements is likely not worthwhile."
Furthermore, Khan states that in lung cancer prevention studies, selenium-supplementation and beta-carotene have been demonstrated to lack benefit.
He continues:
"Foods are very complex and there are likely traveling companions that we haven't identified that are protecting against cancer."
98 women were randomly assigned by Khan and colleagues to receiver either placebo or mixed soy isoflavones supplement.
Over 4,000 breast cancer epithelial cells were identified in the participants, by fine needle aspiration biopsy. Levels of Ki-69, an established protein marker of cancer cell growth, were assessed by the team at six months.
The researchers observed no difference at six months in women receiving mixed soy isoflavones supplement or those receiving placebo. Although, the researchers found that the level of Ki-67 rose from 1.71 to 2.18 among pre-menopausal women, indicating a negative effect of the supplementation.
Khan says:
"This was a small finding, but one that should suggest caution."
Written by Grace Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today
MLA
31 May. 2012. <http://www.medicalnewstoday.com/articles/241370.php>
APA
http://www.medicalnewstoday.com/articles/241370.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'Soy Isoflavone Supplementation Not Effective In Breast Cancer Protection'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




